2-(2-methoxy-4-(4-methylpiperazin-1-yl)phenylamino)-5-methyl-5H-benzo[d]pyrimido[4,5-f][1,3]diazepin-6(7H)-one

ID: ALA4758523

PubChem CID: 162656767

Max Phase: Preclinical

Molecular Formula: C24H27N7O2

Molecular Weight: 445.53

Molecule Type: Unknown

This compound is available for customization.

Associated Items:

Names and Identifiers

Canonical SMILES:  COc1cc(N2CCN(C)CC2)ccc1Nc1ncc2c(n1)-c1ccccc1NC(=O)N2C

Standard InChI:  InChI=1S/C24H27N7O2/c1-29-10-12-31(13-11-29)16-8-9-19(21(14-16)33-3)26-23-25-15-20-22(28-23)17-6-4-5-7-18(17)27-24(32)30(20)2/h4-9,14-15H,10-13H2,1-3H3,(H,27,32)(H,25,26,28)

Standard InChI Key:  YAOKKCKFBFQDFG-UHFFFAOYSA-N

Molfile:  

 
     RDKit          2D

 33 37  0  0  0  0  0  0  0  0999 V2000
    5.5662  -14.0532    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5651  -14.8727    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.2731  -15.2817    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    6.2713  -13.6443    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9830  -14.8736    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    6.9799  -14.0496    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6250  -13.5276    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4328  -13.7028    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7942  -14.4463    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    8.4420  -15.1966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.6369  -15.3843    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.3984  -16.1740    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.9641  -16.7766    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.7714  -16.5842    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    9.0061  -15.7949    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    8.9377  -13.0602    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    4.8570  -15.2807    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.8564  -16.0979    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1482  -16.5044    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1473  -17.3209    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8552  -17.7308    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5656  -17.3184    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5631  -16.5033    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    3.4413  -16.0945    0.0000 O   0  0  0  0  0  0  0  0  0  0  0  0
    2.7328  -16.5018    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8556  -18.5480    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    4.1455  -18.9537    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.1440  -19.7674    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8501  -20.1794    0.0000 N   0  0  0  0  0  0  0  0  0  0  0  0
    5.5594  -19.7717    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    5.5625  -18.9519    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    4.8474  -20.9966    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
    7.4360  -12.7326    0.0000 C   0  0  0  0  0  0  0  0  0  0  0  0
  1  2  2  0
  2  3  1  0
  3  5  2  0
  6  4  2  0
  4  1  1  0
  5  6  1  0
  6  7  1  0
  5 11  1  0
  7  8  1  0
  8  9  1  0
 10  9  1  0
 10 11  2  0
 11 12  1  0
 12 13  2  0
 13 14  1  0
 14 15  2  0
 15 10  1  0
  8 16  2  0
  2 17  1  0
 17 18  1  0
 18 19  2  0
 19 20  1  0
 20 21  2  0
 21 22  1  0
 22 23  2  0
 23 18  1  0
 19 24  1  0
 24 25  1  0
 21 26  1  0
 26 27  1  0
 26 31  1  0
 27 28  1  0
 28 29  1  0
 29 30  1  0
 30 31  1  0
 29 32  1  0
  7 33  1  0
M  END

Alternative Forms

  1. Parent:

    ALA4758523

    ---

Associated Targets(Human)

TNK2 Tclin Tyrosine kinase non-receptor protein 2 (2836 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Associated Targets(non-human)

BaF3 (4657 Activities)
Activity TypeRelationActivity valueUnitsAction TypeJournalPubMed IddoiAssay Aladdin ID

Molecule Features

Natural Product: NoOral: NoChemical Probe: NoParenteral: No
Molecule Type: UnknownTopical: NoFirst In Class: NoBlack Box: No
Chirality: NoAvailability: NoProdrug: No

Drug Indications

MESH IDMESH Heading EFO IDsEFO TermsMax Phase for IndicationReferences

Mechanisms of Action

Mechanism of ActionAction Typetarget IDTarget NameTarget TypeTarget OrganismBinding Site NameReferences

Calculated Properties

Molecular Weight: 445.53Molecular Weight (Monoisotopic): 445.2226AlogP: 3.63#Rotatable Bonds: 4
Polar Surface Area: 85.86Molecular Species: NEUTRALHBA: 7HBD: 2
#RO5 Violations: HBA (Lipinski): 9HBD (Lipinski): 2#RO5 Violations (Lipinski):
CX Acidic pKa: 12.98CX Basic pKa: 7.84CX LogP: 3.04CX LogD: 2.46
Aromatic Rings: 3Heavy Atoms: 33QED Weighted: 0.63Np Likeness Score: -1.22

References

1. Li Z,Powell CE,Groendyke BJ,Gero TW,Feru F,Feutrill J,Chen B,Li B,Szabo H,Gray NS,Scott DA.  (2020)  Discovery of a series of benzopyrimidodiazepinone TNK2 inhibitors via scaffold morphing.,  30  (19): [PMID:32739400] [10.1016/j.bmcl.2020.127456]

Source